Page last updated: 2024-08-23

perfosfamide and Leukemia, Myeloid, Acute

perfosfamide has been researched along with Leukemia, Myeloid, Acute in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-199011 (50.00)18.7374
1990's10 (45.45)18.2507
2000's0 (0.00)29.6817
2010's1 (4.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersson, BS; Champlin, RE; Li, Y; Liu, Y; Murray, D; Popat, U; Tang, X; Valdez, BC1
Herve, P; Peters, A; Tamayo, E1
Dörken, B; Fliedner, TM; Ho, AD; Hunstein, W; Körbling, M; Tischbirek, K; Zipperle, G1
Colvin, M; Santos, GW; Sharkis, SJ1
Andreeff, M; Chen, R; Clarkson, BD; Gulati, SC; Lemoli, RM; Tafuri, A1
Griffin, CA; Piantadosi, S; Rowley, S; Santos, G; Shah, NK; Wingard, JR1
Damon, LE; Linker, CA; Ries, CA; Rugo, HS1
Cassileth, PA; Edelstein, M; Lin, E; Silberstein, L; Spitalnik, S; Stadtmauer, EA1
Acaba, L; Atzpodien, J; Berman, E; Clarkson, B; Crown, J; Doherty, M; Gulati, S; Motzer, R; Reich, L; Yahalom, J1
Altomonte, V; Farmer, ER; Hess, AD; Jones, RJ; Santos, GW; Vogelsang, GB; Yeager, AM1
Andoh, T; Ito, Y; Kawashima, K; Morishima, Y; Morishita, Y; Saito, H; Tanimoto, M; Towatari, M1
Jones, RJ; Miller, CB; Piantadosi, S; Rowley, SD; Zehnbauer, BA1
Davis, JM; Jones, RJ; Miller, CB; Piantadosi, S; Rowley, SD; Santos, GW1
Annett, G; Brooks, J; Kohn, D; Lenarsky, C; Nolta, J; Parkman, R; Petersen, J; Weinberg, K1
Berman, E; Clarkson, B; Cunningham, I; Flomenberg, N; Gee, T; Gulati, SC; O'Reilly, RJ; Sarris, A; Shank, B1
Braine, HG; Colvin, OM; Davis, J; Jones, RJ; Piantadosi, S; Rowley, SD; Saral, R; Sharkis, S; Wingard, J; Yeager, AM1
Colvin, M; Mangan, KF; Przepiorka, D; Rosenfeld, C; Shadduck, RK1
Aoki, N; Murohashi, I; Nara, N; Suzuki, T; Yamashita, Y1
Linch, DC; Singer, CR1
Chang, TT; Chou, TC; Clarkson, B; Colvin, M; Gulati, S1
Chang, TT; Chou, TC; Clarkson, BD; Colvin, M; Gandola, L; Gulati, SC; Ibrahim, SM; Vega, R; Yopp, J1
Debusscher, L; Delforge, A; Loos, M; Rongé-Collard, E; Socquet, M; Stryckmans, P1

Trials

1 trial(s) available for perfosfamide and Leukemia, Myeloid, Acute

ArticleYear
Phase I study of combination drug purging for autologous bone marrow transplantation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Child; Cyclophosphamide; Drug Evaluation; Feasibility Studies; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous; Vincristine

1991

Other Studies

21 other study(ies) available for perfosfamide and Leukemia, Myeloid, Acute

ArticleYear
Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells.
    Experimental hematology, 2018, Volume: 67

    Topics: Alkylating Agents; Apoptosis; Busulfan; Cell Line, Tumor; Chromatin; Cyclophosphamide; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Damage; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; fms-Like Tyrosine Kinase 3; Gene Duplication; Genes, p53; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidative Stress; Precision Medicine; Signal Transduction; Sorafenib; Transplantation Conditioning

2018
Autologous stem cell grafting in acute myeloid leukaemia: technical approach of marrow incubation in vitro with pharmacological agents (prerequisite for clinical applications).
    British journal of haematology, 1983, Volume: 53, Issue:4

    Topics: Cells, Cultured; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute

1983
Autologous transplantation of a bone marrow graft manipulated by chemoseparation to eliminate residual tumor cells.
    Blut, 1983, Volume: 46, Issue:2

    Topics: Bone Marrow; Bone Marrow Transplantation; Brain Neoplasms; Cyclophosphamide; Freezing; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Tissue Preservation; Transplantation, Autologous

1983
Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide.
    Blood, 1980, Volume: 55, Issue:3

    Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Leukemia, Myeloid, Acute; Neoplasm Transplantation; Radiation Chimera; Rats; Rats, Inbred BN; Rats, Inbred Lew

1980
Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
    Leukemia, 1994, Volume: 8, Issue:5

    Topics: Antineoplastic Agents; Cell Cycle; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Interleukin-3; Leukemia, Myeloid, Acute; Male; Tumor Cells, Cultured

1994
Chromosome abnormalities in patients treated with 4-hydroperoxycyclophosphamide-purged autologous bone marrow transplantation.
    Cancer genetics and cytogenetics, 1993, Volume: 65, Issue:2

    Topics: Adolescent; Adult; Bone Marrow Purging; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Female; Hodgkin Disease; Humans; Karyotyping; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic

1993
Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
    Bone marrow transplantation, 1996, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Transplantation, Autologous

1996
Autologous bone marrow transplantation with in vitro chemotherapy purge in first remission of acute myeloid leukemia.
    Progress in clinical and biological research, 1992, Volume: 377

    Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Middle Aged; Transplantation, Autologous

1992
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow.
    Bone marrow transplantation, 1992, Volume: 10, Issue:2

    Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Survival Rate

1992
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
    Blood, 1992, Jun-01, Volume: 79, Issue:11

    Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Skin; Skin Diseases

1992
Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells.
    Cancer research, 1990, Nov-15, Volume: 50, Issue:22

    Topics: Blotting, Northern; Cyclophosphamide; Daunorubicin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Gene Expression; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured

1990
Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.
    Blood, 1991, Aug-15, Volume: 78, Issue:4

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclophosphamide; Drug Resistance; Female; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Stem Cell Assay

1991
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
    Bone marrow transplantation, 1990, Volume: 6, Issue:6

    Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Evaluation Studies as Topic; Graft Survival; Humans; Infant; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Remission Induction; Transplantation, Autologous

1990
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Evaluation Studies as Topic; Freezing; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Organ Preservation; Postoperative Complications; Preoperative Care; Transplantation, Autologous

1989
Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
    Blood, 1989, Volume: 74, Issue:1

    Topics: Age Factors; Bone Marrow; Bone Marrow Transplantation; Colony-Forming Units Assay; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Prognosis; Transplantation, Autologous

1989
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse.
    Blood, 1989, Aug-15, Volume: 74, Issue:3

    Topics: Actuarial Analysis; Adult; Blood Cell Count; Bone Marrow; Bone Marrow Transplantation; Child; Cyclophosphamide; Female; Graft Rejection; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Postoperative Complications; Recurrence; Remission Induction; Transplantation, Autologous

1989
Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Cancer research, 1988, May-01, Volume: 48, Issue:9

    Topics: Adult; Aged; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplastic Stem Cells; Tumor Cells, Cultured

1988
Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.
    Leukemia research, 1987, Volume: 11, Issue:11

    Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cell Survival; Clone Cells; Cyclophosphamide; Cytarabine; Etoposide; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Melphalan; Transplantation, Autologous; Tumor Cells, Cultured

1987
Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors.
    Cancer research, 1987, Jan-01, Volume: 47, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute

1987
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
    Cancer research, 1985, Volume: 45, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Computers; Cyclophosphamide; Drug Synergism; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin

1985
Effect of 4-hydroperoxycyclophosphamide on leukemic and normal human myeloid progenitor cells.
    Leukemia research, 1985, Volume: 9, Issue:5

    Topics: Acute Disease; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myeloid, Acute; Tumor Stem Cell Assay

1985